LivaNova is a medical device company focused on the development and delivery of therapeutic solutions for the benefit of patients, healthcare personnel and healthcare systems. Co.'s principal business franchises, which are also its reportable segments are: Cardiovascular and Neuromodulation. Co.'s cardiovascular business franchise is engaged in the development, production and sale of cardiopulmonary products, heart valves and advanced circulatory support products. Co.'s neuromodulation business franchise designs, develops and markets neuromodulation-based medical devices for the treatment of epilepsy, depression and obstructive sleep apnea. We show 36 historical shares outstanding datapoints in our coverage of LIVN's shares outstanding history.
Understanding the changing numbers of LIVN shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like LIVN versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching LIVN by allowing them to research LIVN shares outstanding history
as well as any other stock in our coverage universe. |
Free LIVN Email Alerts:
Video: Shares Outstanding Importance
